{"id":7830,"date":"2022-09-12T10:41:56","date_gmt":"2022-09-12T08:41:56","guid":{"rendered":"https:\/\/www.iqac.csic.es\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/"},"modified":"2026-06-16T11:11:15","modified_gmt":"2026-06-16T09:11:15","slug":"open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies","status":"publish","type":"post","link":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/","title":{"rendered":"Open submission for journal special issue on Oligonucleotide Based Therapies"},"content":{"rendered":"<p>Dr. <strong>Ramon Eritja<\/strong>, from the<a href=\"https:\/\/www.iqac.csic.es\/research\/departments\/surfactants-and-nanobiotechnology\/nucleic-acids-chemistry\/\" target=\"_blank\" rel=\"noopener\"> <strong>Nucleic Acid Chemistry<\/strong><\/a> group, and Dr. <strong>Santiago Grijalvo<\/strong>, from <a href=\"https:\/\/www.iqac.csic.es\/research\/departments\/surfactants-and-nanobiotechnology\/colloidal-and-interfacial-chemistry\/\" target=\"_blank\" rel=\"noopener\"><strong>Colloidal and Interfacial Chemistry<\/strong> <\/a>group, together with Dr. <strong>Andreia F. Jorge<\/strong>, from <a href=\"https:\/\/www.uc.pt\/fctuc\/dquimica\/Investigacao\/CQC\" target=\"_blank\" rel=\"noopener\"><strong>Coimbra Chemistry Centre<\/strong><\/a> (CQC), acting as guest editors of journal <a href=\"https:\/\/www.mdpi.com\/journal\/pharmaceutics\" target=\"_blank\" rel=\"noopener\">Pharmaceutics<\/a>, of <a href=\"https:\/\/www.mdpi.com\/\" target=\"_blank\" rel=\"noopener\">MDPI Publisher<\/a>, welcome authors to submit their articles on special issues on <strong>Recent Trends in Oligonucleotide Based Therapies<\/strong>.<\/p>\n<p>In the past few decades, significant efforts have been made towards the clinical application of oligonucleotides. However, the potential of the therapeutic applications of RNA-based strategies have recently been spotlighted after the first approval of mRNA vaccines in response to COVID-19 pandemic. These molecules have the power to tackle targets that are usually considered to be \u201cundruggable\u201d by blocking the translation or transcription of a specific gene by stimulating the degradation of a particular messenger RNA.<\/p>\n<p>This Special Issue aims to collect reviews, original research articles, and short communications covering innovative strategies in the design, synthesis, and characterization of therapeutic oligonucleotides as well as advances in their delivery based on nanotechnologies. Research concerning the study of sequence-specific protein\u2013DNA\/RNA interactions will be also considered.<\/p>\n<p>Manuscripts should be submitted online at\u00a0<a href=\"https:\/\/www.mdpi.com\/\" target=\"_blank\" rel=\"noopener\"><strong>www.mdpi.com<\/strong><\/a>\u00a0by\u00a0<a href=\"https:\/\/www.mdpi.com\/user\/register\/\" target=\"_blank\" rel=\"noopener\"><strong>registering<\/strong><\/a>\u00a0and\u00a0<a href=\"https:\/\/www.mdpi.com\/user\/login\/\" target=\"_blank\" rel=\"noopener\"><strong>logging in to this website<\/strong><\/a>. Once you are registered,\u00a0<a href=\"https:\/\/susy.mdpi.com\/user\/manuscripts\/upload\/?journal=pharmaceutics\" target=\"_blank\" rel=\"noopener\"><strong>click here to go to the submission form<\/strong><\/a>.<\/p>\n<p>For all the informations and instructions about the Special Issue, please visit <a href=\"https:\/\/www.mdpi.com\/journal\/pharmaceutics\/special_issues\/rt_olibt\" target=\"_blank\" rel=\"noopener\"><strong>this MDPI page<\/strong><\/a><\/p>\n<p>Deadline for submissions: <strong>31 December 2022<\/strong><\/p>\n<p style=\"text-align: right;\"><strong>IQAC-CSIC Communication<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Ramon Eritja, from the Nucleic Acid Chemistry group, and Dr. Santiago Grijalvo, from Colloidal and Interfacial Chemistry group, together with Dr. Andreia F. Jorge, from Coimbra Chemistry Centre (CQC), acting as guest editors of journal Pharmaceutics, of MDPI Publisher, welcome authors to submit their articles on special issues on Recent Trends in Oligonucleotide Based<a class=\"more-link\" href=\"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/\">Continue reading <span class=\"screen-reader-text\">&#8220;Open submission for journal special issue on Oligonucleotide Based Therapies&#8221;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":3805,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-7830","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Open submission for journal special issue on Oligonucleotide Based Therapies | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Open submission for journal special issue on Oligonucleotide Based Therapies | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\" \/>\n<meta property=\"og:description\" content=\"Dr. Ramon Eritja, from the Nucleic Acid Chemistry group, and Dr. Santiago Grijalvo, from Colloidal and Interfacial Chemistry group, together with Dr. Andreia F. Jorge, from Coimbra Chemistry Centre (CQC), acting as guest editors of journal Pharmaceutics, of MDPI Publisher, welcome authors to submit their articles on special issues on Recent Trends in Oligonucleotide BasedContinue reading &quot;Open submission for journal special issue on Oligonucleotide Based Therapies&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/iqac.csic.es\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-12T08:41:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T09:11:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/banner.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"458\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ana Sotres\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IQAC_CSIC\" \/>\n<meta name=\"twitter:site\" content=\"@IQAC_CSIC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Sotres\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/\"},\"author\":{\"name\":\"Ana Sotres\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/person\\\/ac65d00561d3a6d2810128c46771aff7\"},\"headline\":\"Open submission for journal special issue on Oligonucleotide Based Therapies\",\"datePublished\":\"2022-09-12T08:41:56+00:00\",\"dateModified\":\"2026-06-16T09:11:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/\"},\"wordCount\":241,\"publisher\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/banner.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/\",\"name\":\"Open submission for journal special issue on Oligonucleotide Based Therapies | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/banner.png\",\"datePublished\":\"2022-09-12T08:41:56+00:00\",\"dateModified\":\"2026-06-16T09:11:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/banner.png\",\"contentUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/banner.png\",\"width\":800,\"height\":458},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Open submission for journal special issue on Oligonucleotide Based Therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#website\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/\",\"name\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"description\":\"Chemistry for a better life\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\"},\"alternateName\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.iqac.csic.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\",\"name\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"alternateName\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-favicon-1.png\",\"contentUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-favicon-1.png\",\"width\":512,\"height\":512,\"caption\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/iqac.csic.es\\\/\",\"https:\\\/\\\/x.com\\\/IQAC_CSIC\",\"https:\\\/\\\/www.instagram.com\\\/iqac_csic\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC1JXTOe3-s8UnYu_A6-SI3A\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/iqac-csic\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/person\\\/ac65d00561d3a6d2810128c46771aff7\",\"name\":\"Ana Sotres\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"caption\":\"Ana Sotres\"},\"sameAs\":[\"https:\\\/\\\/www.iqac.csic.es\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Open submission for journal special issue on Oligonucleotide Based Therapies | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/","og_locale":"en_US","og_type":"article","og_title":"Open submission for journal special issue on Oligonucleotide Based Therapies | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","og_description":"Dr. Ramon Eritja, from the Nucleic Acid Chemistry group, and Dr. Santiago Grijalvo, from Colloidal and Interfacial Chemistry group, together with Dr. Andreia F. Jorge, from Coimbra Chemistry Centre (CQC), acting as guest editors of journal Pharmaceutics, of MDPI Publisher, welcome authors to submit their articles on special issues on Recent Trends in Oligonucleotide BasedContinue reading \"Open submission for journal special issue on Oligonucleotide Based Therapies\"","og_url":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/","og_site_name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","article_publisher":"https:\/\/www.facebook.com\/iqac.csic.es\/","article_published_time":"2022-09-12T08:41:56+00:00","article_modified_time":"2026-06-16T09:11:15+00:00","og_image":[{"width":800,"height":458,"url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/banner.png","type":"image\/png"}],"author":"Ana Sotres","twitter_card":"summary_large_image","twitter_creator":"@IQAC_CSIC","twitter_site":"@IQAC_CSIC","twitter_misc":{"Written by":"Ana Sotres","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#article","isPartOf":{"@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/"},"author":{"name":"Ana Sotres","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/person\/ac65d00561d3a6d2810128c46771aff7"},"headline":"Open submission for journal special issue on Oligonucleotide Based Therapies","datePublished":"2022-09-12T08:41:56+00:00","dateModified":"2026-06-16T09:11:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/"},"wordCount":241,"publisher":{"@id":"https:\/\/www.iqac.csic.es\/#organization"},"image":{"@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/banner.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/","url":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/","name":"Open submission for journal special issue on Oligonucleotide Based Therapies | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","isPartOf":{"@id":"https:\/\/www.iqac.csic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#primaryimage"},"image":{"@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/banner.png","datePublished":"2022-09-12T08:41:56+00:00","dateModified":"2026-06-16T09:11:15+00:00","breadcrumb":{"@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#primaryimage","url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/banner.png","contentUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/banner.png","width":800,"height":458},{"@type":"BreadcrumbList","@id":"https:\/\/www.iqac.csic.es\/en\/open-submission-for-journal-special-issue-on-oligonucleotide-based-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.iqac.csic.es\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Open submission for journal special issue on Oligonucleotide Based Therapies"}]},{"@type":"WebSite","@id":"https:\/\/www.iqac.csic.es\/#website","url":"https:\/\/www.iqac.csic.es\/","name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","description":"Chemistry for a better life","publisher":{"@id":"https:\/\/www.iqac.csic.es\/#organization"},"alternateName":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.iqac.csic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.iqac.csic.es\/#organization","name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","alternateName":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","url":"https:\/\/www.iqac.csic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2025\/11\/cropped-favicon-1.png","contentUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2025\/11\/cropped-favicon-1.png","width":512,"height":512,"caption":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC"},"image":{"@id":"https:\/\/www.iqac.csic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/iqac.csic.es\/","https:\/\/x.com\/IQAC_CSIC","https:\/\/www.instagram.com\/iqac_csic","https:\/\/www.youtube.com\/channel\/UC1JXTOe3-s8UnYu_A6-SI3A","https:\/\/www.linkedin.com\/company\/iqac-csic\/"]},{"@type":"Person","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/person\/ac65d00561d3a6d2810128c46771aff7","name":"Ana Sotres","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","caption":"Ana Sotres"},"sameAs":["https:\/\/www.iqac.csic.es\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/comments?post=7830"}],"version-history":[{"count":1,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7830\/revisions"}],"predecessor-version":[{"id":8647,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7830\/revisions\/8647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/media\/3805"}],"wp:attachment":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/media?parent=7830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/categories?post=7830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/tags?post=7830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}